Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Bjerregaard Stage

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Ugeskrift for Laeger|May 9, 2007
[Acute pharmacological treatment of depression]Kurt Bjerregaard Stage, Claus Hauregaard Sørensen
International Journal of Nursing Studies|May 25, 2012
Explanatory models of depression and treatment adherence to antidepressant medication: a qualitative interview studyNiels Buus, Helle Johannessen, Kurt Bjerregaard Stage
Ugeskrift for Laeger|April 23, 2004
[Depression]Kurt Bjerregaard Stage, Piet Casier, Oleg Trosko
Ugeskrift for Laeger|January 12, 2011
[Risk of affective disorder in multiple sclerosis]Elsebeth Nylev Stenager, Kurt Bjerregaard Stage, Egon Stenager
Ugeskrift for Laeger|December 15, 2007
[Lithium versus antidepressants in prevention of unipolar depression. A survey of a Cochrane review]Kurt Bjerregaard Stage, Jens Kristoffersen, Claus Havregaard Sørensen
Psychopathology|September 25, 2003
Gender differences in severity, symptomatology and distribution of melancholia in major depressionMalene Grubbe Hildebrandt, Kurt Bjerregaard Stage, Per Kragh-Soerensen, et al.
Nordic Journal of Psychiatry|February 27, 2004
Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A reviewRie Lambaek Mikkelsen, Thomas Middelboe, Charlotta Pisinger, et al.
Ugeskrift for Laeger|November 19, 2008
[Treatment of psychotic depression]Jens Kristoffersen, Claus Havregaard Sørensen, Connie Thurøe Nielsen, et al.
The American Journal of Psychiatry|August 29, 2003
Are gender differences important for the clinical effects of antidepressants?Malene Grubbe Hildebrandt, Ewout Willem Steyerberg, Kurt Bjerregaard Stage, et al.
Endocrine Connections|February 24, 2018
Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOSDorte Glintborg, Magda Lambaa Altinok, Pernille Ravn, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Ugeskrift for Laeger|May 9, 2007
[Acute pharmacological treatment of depression]Kurt Bjerregaard Stage, Claus Hauregaard Sørensen
International Journal of Nursing Studies|May 25, 2012
Explanatory models of depression and treatment adherence to antidepressant medication: a qualitative interview studyNiels Buus, Helle Johannessen, Kurt Bjerregaard Stage
Ugeskrift for Laeger|April 23, 2004
[Depression]Kurt Bjerregaard Stage, Piet Casier, Oleg Trosko
Ugeskrift for Laeger|January 12, 2011
[Risk of affective disorder in multiple sclerosis]Elsebeth Nylev Stenager, Kurt Bjerregaard Stage, Egon Stenager
Ugeskrift for Laeger|December 15, 2007
[Lithium versus antidepressants in prevention of unipolar depression. A survey of a Cochrane review]Kurt Bjerregaard Stage, Jens Kristoffersen, Claus Havregaard Sørensen
Psychopathology|September 25, 2003
Gender differences in severity, symptomatology and distribution of melancholia in major depressionMalene Grubbe Hildebrandt, Kurt Bjerregaard Stage, Per Kragh-Soerensen, et al.
Nordic Journal of Psychiatry|February 27, 2004
Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A reviewRie Lambaek Mikkelsen, Thomas Middelboe, Charlotta Pisinger, et al.
Ugeskrift for Laeger|November 19, 2008
[Treatment of psychotic depression]Jens Kristoffersen, Claus Havregaard Sørensen, Connie Thurøe Nielsen, et al.
The American Journal of Psychiatry|August 29, 2003
Are gender differences important for the clinical effects of antidepressants?Malene Grubbe Hildebrandt, Ewout Willem Steyerberg, Kurt Bjerregaard Stage, et al.
Endocrine Connections|February 24, 2018
Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOSDorte Glintborg, Magda Lambaa Altinok, Pernille Ravn, et al.
Pageof 2